Abstract
A new, convenient and high yield route to luzindole, the most commonly used melatonin receptor antagonist, is described. The new method involves the Sonogashira coupling reaction between 2-iodoaniline and 3-phenyl-1-propyne followed by cyclisation of the adduct formed, C-3 indole nitroolefination with 1-(dimethylamino)-2-nitroethylene/TFA, reduction to the respective tryptamine and finally acetylation.
Keywords: Luzindole, melatonin receptor antagonist, ortho-alkynylanilines, nitroolefination, 2-benzyltryptamides
Letters in Organic Chemistry
Title: Melatonin Receptor Antagonist Luzindole: A Facile New Synthesis
Volume: 5 Issue: 6
Author(s): Andrew Tsotinis and Pandelis A. Afroudakis
Affiliation:
Keywords: Luzindole, melatonin receptor antagonist, ortho-alkynylanilines, nitroolefination, 2-benzyltryptamides
Abstract: A new, convenient and high yield route to luzindole, the most commonly used melatonin receptor antagonist, is described. The new method involves the Sonogashira coupling reaction between 2-iodoaniline and 3-phenyl-1-propyne followed by cyclisation of the adduct formed, C-3 indole nitroolefination with 1-(dimethylamino)-2-nitroethylene/TFA, reduction to the respective tryptamine and finally acetylation.
Export Options
About this article
Cite this article as:
Tsotinis Andrew and Afroudakis A. Pandelis, Melatonin Receptor Antagonist Luzindole: A Facile New Synthesis, Letters in Organic Chemistry 2008; 5 (6) . https://dx.doi.org/10.2174/157017808785740561
DOI https://dx.doi.org/10.2174/157017808785740561 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hydrolyzed Rutin Decreases Worsening of Anaplasia in Glioblastoma Relapse
CNS & Neurological Disorders - Drug Targets Intravenous Immunoglobulin Treatment Preserves and Protects Primary Rat Hippocampal Neurons and Primary Human Brain Cultures Against Oxidative Insults
Current Alzheimer Research Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands
Current Topics in Medicinal Chemistry Pharmacogenetics of Opioids for the Treatment of Acute Maternal Pain During Pregnancy and Lactation
Current Drug Metabolism Studying the Natively Unfolded Neuronal Tau Protein by Solution NMR Spectroscopy
Protein & Peptide Letters Developmental Synaptogenesis and General Anesthesia: A Kiss of Death?
Current Pharmaceutical Design Mutagenic Approaches to Modifying Gap Junction Phenotype
Current Drug Targets Prediction of Cell Wall Lytic Enzymes Using Chous Amphiphilic Pseudo Amino Acid Composition
Protein & Peptide Letters Herbal and Traditional Chinese Medicine for the Treatment of Cardiovascular Complications in Diabetes Mellitus
Current Diabetes Reviews Clinical Development of MET Targeted Therapy For Human Cancer
Current Cancer Therapy Reviews Monocarboxylate Transporter 1 in Brain Diseases and Cancers
Current Drug Metabolism Establishment of Method for the Determination of Aggregated α-Synuclein in DLB Patient Using RT-QuIC Assay
Protein & Peptide Letters Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia
Current Pharmaceutical Design Effects of Myricitrin and Relevant Molecular Mechanisms
Current Stem Cell Research & Therapy Meet Our Regional Editor
CNS & Neurological Disorders - Drug Targets Hypertension in Hemodialysis Patients
Current Hypertension Reviews Neuroimaging Correlates of Pharmacological and Psychological Treatments for Specific Phobia
CNS & Neurological Disorders - Drug Targets Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
CNS & Neurological Disorders - Drug Targets New Psychoactive Substances: A Matter of Time
Current Neuropharmacology Mitochondrial Uncoupler Proteins
Current Enzyme Inhibition